50% Patient Treatment Milestone in Human Nerve Trial
Filed with ASX · · 3 pages · English
Earlier from Orthocell
- Orthocell Granted European Tendon Regeneration Patent
- Ortho-ATI Case Study Publication
- Orthocell Commences Treatment of Its 1,000th Patient
- Orthocell Granted European Cartilage Regeneration Patent
- Orthocell Receives CE Mark for CelGro
Later from Orthocell
- New Patent for Suture-Less Repair of Soft Tissue Secured
- Orthocell Granted Canadian Tendon Regeneration Patent
- Appendix 4C - quarterly
- Positive CelGro Study Results in ACL Reconstruction
- New Cell Factory Patent Granted in the US
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell